1. Home
  2. COMP vs GRFS Comparison

COMP vs GRFS Comparison

Compare COMP & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COMP
  • GRFS
  • Stock Information
  • Founded
  • COMP 2012
  • GRFS 1940
  • Country
  • COMP United States
  • GRFS Spain
  • Employees
  • COMP N/A
  • GRFS N/A
  • Industry
  • COMP EDP Services
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • COMP Technology
  • GRFS Health Care
  • Exchange
  • COMP Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • COMP 4.9B
  • GRFS 5.9B
  • IPO Year
  • COMP 2021
  • GRFS 2006
  • Fundamental
  • Price
  • COMP $10.47
  • GRFS $8.80
  • Analyst Decision
  • COMP Strong Buy
  • GRFS Hold
  • Analyst Count
  • COMP 9
  • GRFS 1
  • Target Price
  • COMP $10.39
  • GRFS $10.30
  • AVG Volume (30 Days)
  • COMP 14.4M
  • GRFS 771.2K
  • Earning Date
  • COMP 11-04-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • COMP N/A
  • GRFS 1.62%
  • EPS Growth
  • COMP N/A
  • GRFS N/A
  • EPS
  • COMP N/A
  • GRFS 0.64
  • Revenue
  • COMP $6,642,200,000.00
  • GRFS $8,821,017,248.00
  • Revenue This Year
  • COMP $24.14
  • GRFS $5.31
  • Revenue Next Year
  • COMP $12.59
  • GRFS $6.02
  • P/E Ratio
  • COMP N/A
  • GRFS $16.95
  • Revenue Growth
  • COMP 24.27
  • GRFS 7.31
  • 52 Week Low
  • COMP $5.10
  • GRFS $6.19
  • 52 Week High
  • COMP $11.03
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • COMP 75.16
  • GRFS 47.98
  • Support Level
  • COMP $9.12
  • GRFS $8.33
  • Resistance Level
  • COMP $11.03
  • GRFS $8.64
  • Average True Range (ATR)
  • COMP 0.43
  • GRFS 0.22
  • MACD
  • COMP 0.14
  • GRFS 0.04
  • Stochastic Oscillator
  • COMP 79.86
  • GRFS 80.14

About COMP Compass Inc.

Compass Inc provides an end-to-end platform that empowers residential real estate agents to deliver exceptional service to seller and buyer clients. The platform includes an integrated suite of cloud-based software for customer relationship management, marketing, client service and other critical functionality, all custom-built for the real estate industry and enabling core brokerage services. Business operations are conducted in the United States and earn revenue domestically.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: